[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576000":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":41,"collaborators":18,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":18,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":18,"enrollmentInfo":52,"targetDuration":18,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":18,"overallStatus":63,"whyStopped":18,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Malaya","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","Intervention group participants will receive 24 weeks of free, unlimited access to the CareAide® app.\n\nThe CareAide® app will help the intervention group track their medication, view health statistics, help in remote management, act as a health diary, act as a virtual drug cabinet, access medical record files, educate patients and their families, and foster community among afflicted patients.\n\nParticipants will be assisted by the study coordinator to download the App onto their smartphones and how to navigate the app upon recruitment. They will be asked to use the app to manage their medications for a period of 24 weeks. Participants in the IG will participate in the use of the app for from 0 to 24 weeks while the control group will continue with their usual routine. Assessment of adherence levels and pertinent clinical outcomes is scheduled at the end of 24 weeks of the intervention following the enrolment of participants for both study groups.",[13],"Other: CareAide® Medication Adherence Mobile Application",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Participants in the control group will continue with their usual routine without being aware of the existence of the app. Assessment of adherence levels and pertinent clinical outcomes is scheduled at the end of 24 weeks of the intervention following the enrolment of participants for both study groups.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"CareAide® Medication Adherence Mobile Application","CareAide® app is one of the mobile apps in assisting and improving patients' adherence to medications. It is an unique health-tech and insure-tech company with expertise in behavioural science, chronic condition management and technology. The app aims to help patients with chronic conditions live a better everyday life and empower their families and the ecosystem around the patients to drive better outcomes. They have the clinically validated approach to improving adherence. Using behavioural science and smart tech, they improve the day-to-day life of patients, and importantly, empower both patients and health care providers with the digital tools and near real-time insights to proactively manage risks, intervene early to avoid patient emergencies and to help to provide a better customer satisfaction.",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Hooi Chin Beh","CONTACT","+60124438038","hcbeh@ummc.edu.my",[31],{"facility":32,"status":18,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":18,"geoPoint":18,"contacts":38},"Universiti Malaya Medical Centre","Petaling Jaya","Kuala Lumpur","50603","Malaysia","MY",[39],{"name":26,"role":27,"phone":40,"phoneExt":18,"email":29},"+6012 443 8038",{"type":42,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100576000","implementation-and-effectiveness-of-careaide-app-for-people-with-cardiometabolic-diseases-at-a-primary-care-clinic-100576000",false,"NCT06779591","Implementation and Effectiveness of \"CareAide® App\" for People with Cardiometabolic Diseases At a Primary Care Clinic","Implementation and Effectiveness of the Medication Adherence \"CareAide® App\" for People with Cardiometabolic Diseases At an Academic Primary Care Clinic in Malaysia: a Hybrid Implementation-effectiveness Study","Inclusion Criteria:\n\n* Above 18 years old\n* Medically diagnosed with either hypertension, type 2 diabetes and dyslipidemia for at least 6 months as listed in electronic health records\n* Exhibit a low adherence indicated by Malaysia Medication Adherence Assessment Tool (MyMAAT) scores of \\\u003C54 scores\n* Taking at least one type of medication daily, three medications daily or two medications with multiple dosing intervals prescribed,\n* Owns and able to use a smartphone\n* Able to read English or Malay\n\nExclusion Criteria:\n\n* Individuals who are pregnant, already using any adherence apps or diagnosed with any terminal illnesses, visually impaired, disability or mental health related illnesses","ALL","18 Years",{"count":53,"type":54},200,"ESTIMATED","INTERVENTIONAL",[57],"NA","This study aims to explore the barriers and facilitators to implement CareAide® app among healthcare providers and patients at a primary care clinic in Malaysia.\n\nThis is an implementation-qualitative research study meaning researchers will collect data regarding the adoption rate, ease of implementation and adoption, and patient's willingness to use the application. The researchers will also compare the effectiveness of the application as a tool to remind patients to take their medicine, by comparing between a group of participants who use the app and another group of participants who do not use the app.\n\nThis study requires participants to use an app, then attend some routine follow-ups and be administered blood tests, followed by an interview to collect their opinions, feelings, and experiences.",[60,61,62],"Hypertension","Diabetes Mellitus Type 2","Dyslipidemia","NOT_YET_RECRUITING","2025-03-25",{"date":66,"type":67},"2025-03-30","ACTUAL",{"date":69,"type":54},"2025-04-30",{"date":71,"type":54},"2026-12",{"name":5,"class":6},1]